<ѻý>Treatment of Smoldering Myeloma Cuts Progression Rate in Halfѻý> Daratumumab significantly improved PFS, OS, but identity of high-risk population remains elusive Dec 09, 2024
<ѻý>Novel BTK Inhibitor Succeeds in Heavily Pretreated Immune Thrombocytopeniaѻý> Rilzabrutinib specifically designed to reduce platelet-targeting autoantibodies Dec 08, 2024
<ѻý>Dietary Intervention Shows Promise in Blood Cancersѻý> High-fiber diets tied to improved outcomes in stem-cell transplants, slowing myeloma precursors Dec 08, 2024
<ѻý>Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALLѻý> Cytokine release syndrome developed in all patients, including grade 3/4 events in nearly half Dec 07, 2024
<ѻý>New Standard for Newly Diagnosed Pediatric B-Cell Acute Lymphoblastic Leukemiaѻý> Blinatumomab consolidation reduced risk of relapse by 61% versus chemotherapy alone Dec 07, 2024
<ѻý>Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITPѻý> Drug may potentially "transform" approach to upfront treatment, investigator says Dec 07, 2024
<ѻý>AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resignsѻý> News, features, and commentary about cancer-related issues Dec 05, 2024
<ѻý>Stem Cell Selection Unneeded for SSc Transplant Therapy?ѻý> Small trial suggests a simpler path to defeat systemic sclerosis Dec 03, 2024
<ѻý>Year in Review: Multiple Myelomaѻý> A drug comeback, new FDA approvals, and a new standard for transplant-ineligible patients Dec 02, 2024
<ѻý>New CAR-T Drug Induces Durable Remissions in ALL, Published Data Showѻý> Results of FELIX study supported obecabtagene autoleucel's recent FDA approval Nov 27, 2024
<ѻý>FDA Investigating Blood Cancer Risk With Gene Therapy Skysonaѻý> Agency is evaluating the need for further regulatory action Nov 27, 2024
<ѻý>Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?ѻý> News, features, and commentary about cancer-related issues Nov 22, 2024
<ѻý>FDA Approves First Menin Inhibitor for Acute Leukemiaѻý> Complete responses in 21% of patients treated with single-agent revumenib Nov 15, 2024
<ѻý>Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancerѻý> News, features, and commentary about cancer-related issues Nov 15, 2024
<ѻý>Electronic Symptom Screening in Kids With Cancer Boosts Quality of Careѻý> Improvements seen in pain, neuropathy, and cognitive function Nov 13, 2024
<ѻý>U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Painѻý> Health news and commentary gathered by ѻý staff Nov 11, 2024
<ѻý>New CAR T-Cell Therapy Approved for Leukemiaѻý> Obecabtagene autoleucel has no requirement for a REMS program Nov 08, 2024
<ѻý>Asymptomatic or Minimally Symptomatic Myelofibrosisѻý> Momentum grows for earlier intervention, including pre-fibrotic disease Nov 04, 2024
<ѻý>Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancerѻý> News, features, and commentary about cancer-related issues Nov 01, 2024
<ѻý>Early Smoking Cessation After Cancer Diagnosis Tied to Better Survivalѻý> Largest survival benefit observed in patients who entered a cessation program within 6 months Oct 31, 2024
<ѻý>Personalized Breast Cancer Treatment; Insights Into HPV in Men; Exercise and Cancerѻý> News, features, and commentary about cancer-related issues Oct 25, 2024
<ѻý>Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphomaѻý> May become "treatment of choice" over brentuximab vedotin for all disease stages Oct 16, 2024
<ѻý>Study Details Perinatal Risks of Blood Cancers Diagnosed in Pregnancyѻý> Likelihood of severe maternal morbidity more than 20 times higher versus the general population Oct 11, 2024
<ѻý>Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?ѻý> News, features, and commentary about cancer-related issues Oct 10, 2024
<ѻý>Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Riskѻý> 10% of patients in trials leading to eli-cel's approval developed MDS or AML Oct 09, 2024
<ѻý>Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancerѻý> News, features, and commentary about cancer-related issues Oct 04, 2024
<ѻý>Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlementѻý> News, features, and commentary about cancer-related issues Sep 26, 2024
<ѻý>Sickle Cell Disease Drug Pulled From Global Marketsѻý> Benefits of voxelotor (Oxbryta) no longer outweigh the risks, Pfizer says Sep 26, 2024
<ѻý>Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxisѻý> Fidanacogene elaparvovec reduces bleeding episodes by 71% after a single infusion Sep 25, 2024
<ѻý>Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?ѻý> News, features, and commentary about cancer-related issues Sep 19, 2024
<ѻý>Chemo-Free Triplet Yields 68% Response Rate in Richter Transformationѻý> Regimen tops best historical response rate with chemoimmunotherapy in this setting Sep 16, 2024
<ѻý>Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancerѻý> News, features, and commentary about cancer-related issues Sep 12, 2024
<ѻý>Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatmentsѻý> Incidence almost identical to that with standard cancer treatment in randomized trials Sep 11, 2024
<ѻý>Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCDѻý> For patients with vaso-occlusive episodes, lactated Ringer was better than normal saline Sep 09, 2024
<ѻý>Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupusѻý> Patient achieves remission with biologic agent currently used for myeloma Sep 04, 2024
<ѻý>The Higher the Disability Burden From Disease, the Higher the Suicide Riskѻý> Having a medical condition was tied to increased risk of suicide in a dose-response-like manner Sep 04, 2024
<ѻý>Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancersѻý> Systematic review and meta-analysis finds CAR T-cell-specific toxicities only account for 11.5% Sep 04, 2024
<ѻý>BTK Inhibitor Active in Half of Patients With Richter Transformationѻý> Responses to pirtobrutinib observed in patients with previously treated disease Sep 03, 2024
<ѻý>Lung Function Stable in Sickle Cell Patients After Non-Myeloablative Transplantѻý> Results from some pulmonary function tests even showed improvement 3 years post-transplant Aug 28, 2024
<ѻý>Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplantsѻý> Better survival in one registry study, detriment with class I HLA mismatch in another Aug 27, 2024